Genmab — August 2022
-
Thanks for the remarks EL. I was asking for a matrix and not a duo perspektiv FYI. Andrew chose to compare shareholder value with successful treatments and fair enough. Andrew could also claim that successful treatments is equal high salaries... Ref. 20:11 Im not asking for any date Im asking for clear strategy rather than cash piling company. lol to be continued
-
Solsen - hvilke andre bio selskaber har en kontantbeholdning der overgår Genmab?
-
Så lader vi blot dit postulat stå ubesvaret @Solsen
-
Godmorgen.
-
Godmorgen.
-
Asien: Plusser i Tokyo anført af Olympus og NEC https://www.proinvestor.com/investornyt/872622/asien-plusser-i-tokyo-anfort-af-olympus-og-nec
-
Tirsdagens danske avisuddrag med inflationshjælp, klima og Ørsted https://www.proinvestor.com/investornyt/872627/tirsdagens-danske-avisuddrag-med-inflationshjaelp-klima-og-orsted
-
Aktier: Novo Nordisk, Lundbeck, AMBU og mange andre skubber et USD boom foran sig ind i 2023 https://www.proinvestor.com/boards/105755/
-
Transcript - Q&A Session med Vice President, Head of Investor Relations Andrew Carlsen, Q2 Genmab 29.08.2022 https://www.proinvestor.com/ir/q-and-a/dk
-
Dagens finanskalender med bla. Ennogie https://www.proinvestor.com/finanskalender
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind